Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darapladib for Coronary Atherosclerosis (AIM III)
NCT01067339Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2010
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darapladib in Coronary atherosclerosis (CAD), sponsored by Mayo Clinic. Started Feb 2010; status: completed.
02
Drugs
darapladib
03
Conditions
Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT01067339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067339.